Cilastatin used for the treatment of sepsis

摘要

The present invention relates to the treatment of sepsis and sepsis-related acute kidney injury (SA-AKI). More particularly, it relates to cilastatin used for methods of treating sepsis and / or SA-AKI and reducing its associated mortality in mammals. It further relates to a method for treating sepsis and / or SA-AKI, and to a pharmaceutical composition used for the method of the invention.